MedTrace Logo

Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease

NCT05962476 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2025-08-01

No results posted yet for this study

Summary

Small exploratory pilot study to assess effects of a transcutaneous vibro-acoustic therapy device (Apollo Neuro) in people with Parkinson's disease (PD).

Conditions

  • Parkinson Disease

Interventions

DEVICE

Transcutaneous vibro-acoustic device

Wearable device which sends low-frequency sound vibrations through the skin.

Sponsors & Collaborators

Principal Investigators

  • Prabesh Kanel, PhD · University of Michigan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-09
Primary Completion
2023-08-09
Completion
2023-08-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05962476 on ClinicalTrials.gov